Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

DECIBEL THERAPEUTICS, INC.

(DBTX)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 30-09-2022
3.460 USD   +1.76%
20/09Decibel Therapeutics kondigt de indiening aan van een Investigational New Drug (IND) aanvraag voor de belangrijkste gentherapiekandidaat DB-OTO
CI
13/09Decibel Therapeutics, Inc. Kondigt wijzigingen in de leiding aan
CI
10/08Decibel Therapeutics, Inc. Rapporteert Winstresultaten voor het Tweede Kwartaal en de Zes Maanden Eindigend op 30 Juni, 2022
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op DECIBEL THERAPEUTICS, INC.
22/09Decibel Therapeutics to Participate in the Jefferies Cell and Genetic Medicine Summit
21/09Decibel Therapeutics Announces Submission of Investigational New Drug Application for L..
20/09Decibel Therapeutics Files Investigational New Drug Application With US FDA for Product..
20/09Decibel Therapeutics, Inc. : Other Events (form 8-K)
20/09Decibel Therapeutics Announces Submission of Investigational New Drug (IND) Application..
20/09Decibel Therapeutics Announces Submission of Investigational New Drug Application for L..
13/09Decibel Therapeutics, Inc. : Change in Directors or Principal Officers (form 8-K)
13/09Decibel Therapeutics, Inc. Announces Executive Changes
13/09Decibel Therapeutics, Inc. Announces Chief Financial Officer Changes
31/08Decibel Therapeutics to Participate in Upcoming Investor Conferences
31/08Decibel Therapeutics to Participate in Upcoming Investor Conferences
25/08Absci Decibel Therapeutics Files For Up to $250 Million Mixed Shelf
10/08Decibel Therapeutics, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
10/08Decibel Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Update
10/08Decibel Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Update
10/08DECIBEL THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition..
10/08Decibel Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Mont..
28/06Top Midday Gainers
28/06Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday
28/06Top Premarket Gainers
28/06Decibel Therapeutics Says Topline Trial Shows DB-020 Protected 87% of Cisplatin Chemoth..
28/06Decibel Therapeutics, Inc. : Other Events (form 8-K)
28/06Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Cl..
28/06Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Cl..
28/06Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Cl..
17/06Decibel Therapeutics, Inc. : Submission of Matters to a Vote of Security Holders (form 8-K..
06/06Decibel Therapeutics to Present at the Jefferies Global Healthcare Conference
03/06Decibel Therapeutics to Present at the Jefferies Global Healthcare Conference
17/05Decibel Therapeutics to Present at the H.C. Wainwright Global Investment Conference
17/05Decibel Therapeutics to Present at the H.C. Wainwright Global Investment Conference
12/05Decibel Therapeutics Reports First Quarter 2022 Financial Results and Corporate Update
12/05DECIBEL THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition..
12/05Decibel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 3..
02/05Decibel Therapeutics to Present at the†American Society of Gene and Cell Therapy (ASGCT..
02/05Decibel Therapeutics to Present at the†American Society of Gene and Cell Therapy (ASGCT..
22/03Decibel Therapeutics to Participate in Upcoming Investor Conferences
21/03Decibel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Co..
21/03Decibel Therapeutics Files $200 Million Mixed Shelf
18/03Decibel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Co..
18/03Decibel Therapeutics : Annual Report (Form 10-K)
18/03DECIBEL THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition..
18/03Decibel Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31..
10/02Decibel Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Co..
10/02Decibel Therapeutics Reports on Continued Progress of Lead Gene Therapy Product Candida..
10/02Decibel Therapeutics Announces the Presentation of Preclinical Data on Lead Gene Therap..
31/01Decibel Therapeutics to Present at the 45th Annual Association for Research in Otolaryn..
04/01Decibel Therapeutics to Present at the H.C. Wainwright BioConnect Conference
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) added to N..
2021Decibel Therapeutics, Inc. : Change in Directors or Principal Officers (form 8-K)
2021Decibel Therapeutics Announces Appointments of Alison Finger, MBA and Saraswathy Nochur..
2021Decibel Therapeutics, Inc. Announces Board Changes
2021Decibel Therapeutics Announces Appointments of Alison Finger, MBA and Saraswathy Nochur..
2021Regeneron Extends Research Collaboration With Decibel Therapeutics; Decibel Shares Rise..
2021Decibel Therapeutics Announces Extension of Research Term under Strategic Collaboration..
2021Decibel Therapeutics, Inc. Announces Extension of Research Term Under Strategic Collabo..
2021Decibel Therapeutics Reports Third Quarter 2021 Financial Results and Corporate Update
2021DECIBEL THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition..
2021Decibel Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
2021Decibel Therapeutics to Present at the Barclays Gene Editing & Gene Therapy Summit
2021Decibel Therapeutics : to Present at the Jefferies Gene Therapy/Editing Summit
2021Decibel Therapeutics : Announces Publication of Foundational Study of Noise-related Inner ..
2021Decibel Therapeutics : Says Treatment Candidate for Congenital Hear..
2021Decibel Therapeutics : Receives Orphan Drug and Rare Pediatric Disease Designations for DB..
2021Decibel Gets FDA Orphan-Drug, Rare-Pediatric-Disease Designations for DB-OTO
2021Decibel Therapeutics to Present at Upcoming Investor Conferences
2021Decibel Therapeutics Appoints Cynthia Hu, J.D., as Chief Legal Officer and Corporate Se..
2021Decibel Therapeutics Appoints Cynthia Hu as Chief Legal Officer and Corporate Secretary
2021Decibel Therapeutics : Principal Accounting Officer Ronald Vigliott..
2021Decibel Therapeutics, Inc. : Change in Directors or Principal Officers (form 8-K)
2021Decibel Therapeutics, Inc. Announces Executive Changes, Effective September 9, 2021
2021Certain Common Stock of Decibel Therapeutics, Inc. are subject to a Lock-Up Agreement E..
2021Certain Stock Options of Decibel Therapeutics, Inc. are subject to a Lock-Up Agreement ..
2021Decibel Therapeutics : Reports Second Quarter 2021 Financial Results and Corporate Update
2021Decibel Therapeutics : Management's Discussion and Analysis of Financial Condition and Res..
2021Decibel Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 3..
2021North American Morning Briefing: Stock Futures -2-
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc.(NasdaqGS:DBTX) dropped fr..
2021Decibel Therapeutics, Inc. : Change in Directors or Principal Officers (form 8-K)
2021Decibel Therapeutics Names New Board Chairman
2021Decibel Therapeutics : Appoints Dr. William H. Carson as Chairman of the Board of Director..
2021Decibel Therapeutics Appoints Dr. William H. Carson as Chairman of the Board of Directo..
2021Decibel Therapeutics Expands World-Class Scientific Advisory Board
2021Decibel Therapeutics, Inc. Announces Advisory Board Appointments
2021Decibel Therapeutics : to Present at the UBS Global Healthcare Virtual Conference
Volgende evenement op DECIBEL THERAPEUTICS, INC.